CDMO News
Genezen to Acquire uniQure’s Gene Therapy Manufacturing Site
Genezen, a gene therapy CDMO, has announced an agreement to acquire uniQure’s commercial gene therapy operations in Lexington, MA. The acquisition includes a state-of-the-art manufacturing facility and a world-class team of employees. This transaction will enable Genezen to enhance its
2 July 2024